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This article addresses concepts of environmental tobacco smoke (ETS) exposure assessment
relevant for health risk assessment based on human studies. We present issues that should be
considered when selecting a method for ETS exposure assessment for the purposes of health risk
assessment and review data on ETS exposure levels in the workplace and in home environments.
Two types of estimates are needed for a quantitative risk assessment of the health effects resulting
from occupational ETS exposure: a) an unbiased estimate of the exposure-effect (or
dose-response) relation between ETS and the health effect of interest, and b) estimates of the
distribution of ETS exposure in different workplaces. By combining the estimated exposure-effect
relation with information on exposure distribution for a population of interest, we can calculate the
proportions of disease cases attributable to occupational ETS exposure as well as the excess
number of cases due to specified exposure conditions. Several dimensions of the exposure profile
should be considered when assessing ETS exposure for estimating the exposure-effect relation,
including the magnitude of exposure and the biologically relevant time specificity of exposure. The
magnitude of exposure is determined by the ETS source strength, environmental factors modifying
concentrations, and duration of exposure. Time specificity considerations include the latency period
for each health outcome of interest, the time-exposure profile relevant for different disease
mechanisms, and the sensitive age period with regard to health effects. The most appropriate
indicator of ETS exposure depends on these factors and on the time period that can be assessed
with different methods. Key words: exposure assessment, risk assessment, tobacco smoke
pollution, workplace exposure. - Environ Health Perspect 107(suppl 6):829-835 (1999).
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Exposure assessment is an essential element of
the evaluation ofhealth risks ofenvironmental
exposures. In this article, we consider exposure
assessment for environmental tobacco smoke
(ETS), with emphasis on occupational settings.
Substantial research on the adverse health
effects ofETS has already accumulated (1-4).
Many of the studies have been directed at
exposures in residences and involve the effects
ofsmoking in the household on nonsmoking
spouses and children, whereas much less data
are available on theeffects ofoccupational ETS
exposure. This workshop evaluated the evi-
dence on potential health effects resulting from
ETS exposure in theworkplace.
In this article, we consider the exposure
information needed to conduct an informa-
tive risk assessment of the health effects of
ETS based on human studies, whether epi-
demiologic or clinical. We present concepts
of ETS exposure assessment relevant for
health risk assessment based on human
studies. We introduce the most commonly
used ETS exposure assessment methods and
present biologically driven approaches to
guide selection ofthe most appropriate ETS
exposure assessment method for assessing
health risk. We also review data on ETS
exposure levels in the workplace and in the
residence and data on their relations with
reported smoking by others, with the goal of
evaluating their usefulness for assessing the
risk ofETS exposure in theworkplace.
Fundamental Concepts in ETS
Exposure Assessment
Definitions Related toETSExposure
ETS exposure ofnonsmokers is often referred
to as passive smoking or involuntary smoking.
It constitutes the exposure of a nonsmoking
person to tobacco combustion products from
the smoking ofothers (5). First, we consider
fundamental concepts related to exposure.
Concentration refers to the amount of a con-
taminant at a particular location in a particu-
lar medium, e.g., in a specified volume ofair
(6). ETS is a mixture of gaseous compounds
and particles composed ofconcentrations of
several individual constituents. Air pollutant
concentrations are usually expressed as mass
per unit volume, e.g., micrograms per cubic
meter. Exposure is defined as the contact of
pollutant with a susceptible surface of the
human body (6-8). For ETS this definition
implies contact with the eyes, the epithelium
ofthe nose, mouth, and throat, and the lining
of the airways and alveoli. With respect to
time, exposure can be expressed on several
time scales, including instantaneous exposure,
average exposure over a specified time period,
and cumulative exposure (8,9). Dose is
defined as the amount of contaminant that
crosses a boundary ofthe body (6,7,10). Dose
depends on the concentration at which expo-
sure is received, the time course of exposure,
and the physiologic state of the individual.
The amount ofthe pollutant absorbed consti-
tutes the dose to the body, and the amount
that reaches the target organ of the adverse
effect is the biologicallyeffective dose.
The ChainLinkingETSSourcesto
HealthEffects
Figure 1 [from Jaakkola and Jaakkola (9)]
presents the chain that links the sources of
ETS to the exposure of an individual and
finally to the biologically effective dose. The
number of smokers and their smoking pat-
terns in a given space determine the source
strength for ETS. The source strength is a
major determinant of the concentration of
ETS in a given space, but the concentration
is also determined by characteristics of the
space, including the volume ofthe space, the
ventilation rate, and other factors affecting
removal of ETS such as air cleaning. The
contact of the pollutant with the relevant
surfaces of an individual results in exposure.
Dose depends on the concentration of ETS
and the physiologic factors that modify the
uptake of ETS, including lung morphom-
etry and activity level of the individual.
Activity level determines the breathing pat-
tern and thus the ventilation of the lungs
and the sites ofdeposition of ETS compo-
nents. The biologically effective dose further
depends on processes occurring in the body
after uptake, including metabolism and
elimination of the compounds. The differ-
ence between the dose and the biologically
effective dose varies according to the health
outcome: for asthma the dose received in the
lung is probably equivalent to the biologi-
cally effective dose, whereas for lung cancer
patterns ofcarcinogen metabolism and elim-
ination affect the biologically effective doses
ofparticular carcinogens.
Figure 2 presents the sequence from dose
to health effects. For any given biologically
effective dose, the potential health effects may
be modified by individual characteristics that
determine susceptibility to the injury-causing
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Figure 1. The chain linking ETS sources to the exposure of an individual, andfinally to the biologically effective dose.
Different environmental and intrinsic factors that influence or modify exposure and dose are illustrated. Reprinted
from Jaakkola and Jaakkola (9)with permission ofthe EuropeanRespiratoryJoumal.
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Figure 2. The sequence from dose to health effects.
The intrinsic and physiologic factors that determine sus-
ceptibility to detrimental effects of ETS are illustrated.
agents in ETS. These factors have not been
studied extensively, but at least underlying
respiratory or cardiovascular disease and age
appear to be important determinants of sus-
ceptibility. Genetic factors may also modify
responses to tobacco smoke. In addition to
modifying the biologic responses of the
body to the biologically effective dose, fac-
tors determining susceptibility may also
modify the dose itself and the biologically
effective dose, e.g., by affecting the breath-
ing pattern and thus the uptake of ETS or
by influencing the metabolism of absorbed
compounds.
Although concentrations of ETS may
differ in homes and workplaces, the exposures
are expected to be qualitatively similar in
chemical composition. Factors that may lead
to different concentrations in the workplace
compared to the residential environment
include differences in source strength result-
ing from different densities ofsmokers and
different smoking patterns in the two types of
environments, and differences in environ-
mental factors that modify concentrations.
The most significant ofthese environmental
characteristics are the volume of the space
and the air change rate for uncontaminated
air. At anygiven exposure, doses maydiffer in
the home andworkplace settings. Factors that
may lead to different doses in occupational
and residential settings indude those affecting
uptake, particularly differences in activity lev-
els that affect breathing rate and pattern
(mouth vs nose) and thus the ventilation rate
ofthe lungs. Physical activity increases rate of
breathing and lung ventilation and hence the
delivered dose ofETS.
ETSExposureAssessmentforthe
Purposes ofHealthRiskAssessment
The basic aim in assessing personal ETS expo-
sure is to measure the concentrations ofETS
that an individual encounters at different
times as he/she moves through various micro-
environments such as home, workplace, and
public places (9). Data on the time spent in
these microenvironments are also needed to
calculate total personal exposure. To conduct
a quantitative risk assessment ofthe health
effects resulting from occupational ETS expo-
sure, we need two types ofestimates:
An unbiased estimate of the exposure-
effect (or dose-response) relation between
ETS and the health effect ofinterest. Such
an estimate can be derived either from
individual studies or from a meta-analysis
or pooled analysis ofindividual data. The
exposure or dose data should reflect total
personal exposure or exposure from one
source ofinterest ifwe can control for the
other potential sources. Control for other
potential sources can be accomplished as
part ofthe study design, e.g., by studying
working persons married to nonsmokers
or housewives with no workplace expo-
sure, or it can be accomplished by adjust-
ing in the data analysis. Home and work
environments are the major sources of
potential ETS exposure, since most time is
spent in these twoenvironments.
* Estimates ofthe distribution ofETS levels
in different workplaces. For risk assess-
ment we need the full characterization of
workplace exposure distribution. We need
an estimate ofthe proportion ofthe work
force ofinterest that is exposed to ETS in
the workplace and information on the
range of occupational ETS exposures.
Ideally, we prefer to derive these estimates
from random samples ofthe work forces
providing representative frequency distrib-
utions ofETS exposure levels. To extend
risk estimates from the home environment
to the workplace, we need information on
the levels ofoccupational ETS exposure
compared to residential exposure levels.
To use risk estimates based on total per-
sonal exposure, we need information
on the proportion of total exposure
contributed byoccupational exposure.
By combining the estimated exposure-
effect relation with information on exposure
distribution for a population of interest, we
can calculate the proportions ofthe exposed
disease cases (attributable proportion or eti-
ologic fraction) and of all disease cases in
this population (population-attributable
proportion) attributable to occupational
ETS exposure. We can also estimate the
excess number of cases due to specified
exposure conditions.
Next we discuss important issues that
should be considered when selecting an ETS
exposure assessment method for estimating
the exposure-effect relation and review cur-
rently available data on workplace and
residential ETS exposures.
Selection of ETS Exposure
Assessment Method for
Estimating Health Effects
When estimating health effects of ETS
exposure, two dimensions in the ETS expo-
sure profile should be considered (9): quanti-
tative assessment of exposure and time
specificity ofexposure in relation to outcome.
Quantitative ETS exposure assessment
includes the magnitude ofETS concentra-
tion, the duration ofexposure, and the time
pattern ofexposure (changes in the exposure
level over time). The time period ofinterest
depends on the health outcome.
A key issue concerning the timespecificity
ofexposure is the biologically relevant expo-
sure for each health outcome of interest.
Three aspects ofthe time specificity ofexpo-
sure should be considered. First, the latency
period, or the time period from start ofexpo-
sure to manifestation ofthe health outcome,
may vary from a few hours for exacerbation
of asthma to 20 years or more for lung
cancer. Second, the relevant exposure-time
profile may vary considerably from one dis-
ease to another. For example, high but brief
peak levels may be relevant for exacerbations
of asthma, whereas development of lung
cancerlikely reflects cumulative exposure over
long time periods. Third, for some health
outcomes there may be susceptible age or
maturation windows during which exposure
may cause disease, whereas similar exposure
during another period may have less risk or
possibly no effect. For example, the sensitive
period may be relevant when assessing the
adverse effects of a mother's occupational
exposure on the fetus or of household
smoking on lung development ofinfants.
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AssessmentMethods
forETSExposure
ETS is a complex mixture of gases and
particles. The epidemiologic evidence links
the mixture rather than specific components
to health effects. Little is known about the
role ofindividual components in causing spe-
cific adverse health outcomes. In addition,
synergistic effects (interactions) among differ-
ent compounds are likely to be important in
determining health effects. Therefore it is nec-
essary to choose an indicator or a marker for
the entire ETS mixture when assessing ETS
exposure. In developing an exposure assess-
ment strategy, the most appropriate indicator
should be used, considering features of the
pathogenesis ofthe health outcome ofinterest.
The following indicators of ETS have been
widely used in previous studies: individual
chemical compounds measured in the air,
indices derived from questionnaires, and
metabolites ofETS components measured in
biologic specimens (1,9,11). Methods for
ETS exposure assessment are divided into
direct and indirect methods. These methods
are described in more detail in a recent article
by Jaakkola and Jaakkola (9) that also dis-
cusses their strengths and limitations. Personal
monitoring of relevant tobacco smoke con-
stituents is considered to be the most direct
ETS exposure assessment method. Indirect
assessment methods measure concentrations
ofindoor air tobacco smoke compounds with
stationary monitors or collect information on
ETS sources in different microenvironments
and combine these data with information on
time periods spent in each microenvironment,
using mathematical formulas or modeling
approaches. Biomarkers are usually measures
of dose rather than direct or even indirect
measures ofexposure.
As mentioned, chemical compounds in
the air can be measured either with stationary
monitors or with personal monitoring using
samplers worn for several hours to several
days (9). Vapor-phase nicotine is the most
commonly used marker for the gas-phase
constituents ofETS. Other markers ofthe gas
phase include carbon monoxide (CO), nitro-
gen oxides, formaldehyde, and volatile
organic compounds (1,12). Respirable sus-
pended particulates (RSPs) have been mea-
sured most often as a marker ofpartide phase
constituents of ETS. These are particles less
than 2.5 pim in aerodynamic diameter and
thus small enough to enter the peripheral air-
ways and alveoli. Other potential markers of
the particle phase include tobacco-specific
nitrosamines, benzo[a]pyrene, and polycyclic
aromatic hydrocarbons (PAHs) (4,12). The
advantages related to using nicotine and RSPs
as markers have been availability ofvalidated
and easy measurement methods, knowledge
oftheir emission rates from tobacco combus-
tion, and knowledge of their relations to
other ETS components (1,9). In addition,
the presence ofnicotine in air is specific to
tobacco combustion.
Questionnaire-based assessment is the
most widely used exposure assessment
method in epidemiologic studies ofthe health
effects ofETS. Questionnaires are relatively
inexpensive and can be used to assess long-
term ETS exposure, even focusing on past
exposures (9). Questionnaires have been
developed to improve exposure assessment by
considering time specificity of exposure as
well as quantification ofexposure (13-15).
Biomarkers can be considered surrogate
measures of dose. However, the relation
between exposure and the level of a bio-
marker is often complex, as it is modified by
the various factors presented in Figure 1.
Cotinine, one of the major metabolites of
nicotine, has been used commonly as a bio-
marker for both active smoking and ETS
exposure. In adult nonsmokers, its half-life is
from 7 to 40 hr (1,16), and it can be meas-
ured in plasma, urine, and saliva. Hair nico-
tine content is a relatively new biomarker of
ETS that has the advantage of representing
tobacco smoke exposure during the previous
1 to 2 months (17). Adsorption of nicotine
from the surrounding air onto hair appears to
be the primary contributor to the overall
nicotine content in the hair, so hair nicotine
represents exposure rather than dose (18).
Recent reports have assessed protein and
DNA adducts as markers of ETS exposure
(4). The compound 4-aminobiphenyl
(4-ABP) is a known human carcinogen, and
its adduct ofhemoglobin has a half-life of
approximately 4 months (1). Elevated levels
of4-ABP adduct have been observed in asso-
ciation with ETS exposure (19,20). Albumin
adducts ofPAHs is another group ofprotein
adducts measured as markers of ETS (21).
Reports ofother lung carcinogens as potential
biomarkers of ETS, such as 4-(methyl-
nitrosamino)-1-(3-pyridyl)-1-butanol and its
glucuronide, have also been published (4,22).
Selection ofthe Most
Appropriate Method for
ETS Exposure Assessment
Table 1 presents an overview of the time
frames that can be assessed with different indi-
cators ofETS exposure. The time period that
can be assessed with a single measurement and
with repeated measurements is indicated for
each marker. For air concentration measure-
ments, continuous monitoring is also consid-
ered. The last column indicates whether a
given method can be applied for assessment of
current or past exposure. Air concentration
measurements ofETS markers provide assess-
ment ofcurrent exposure on a time frame of
hours to months, depending on whether the
measurements are taken once, repeatedly, or
by continuous monitoring. Measurements of
biomarkers provide assessment ofpast expo-
sure. The exposure window spans hours with
cotinine measurements and months with hair
nicotine and 4-ABP adduct. With repeated
measurements of hair nicotine or 4-ABP
adduct, exposures over years can be assessed.
Questionnaires can be used to assess both cur-
rent and past exposures and to provide assess-
ment forperiods ranging from hours toyears.
Table 2 presents, according to our
judgment, the most likely latency periods for
effects of ETS exposure on four major dis-
eases ofinterest. Development ofnew disease
and exacerbation of established disease are
considered separately for asthma and coro-
nary heart disease (CHD). The latency peri-
ods cover a full spectrum-from hours for
exacerbation of asthma and angina, to days
for exacerbation of asthma, to months for
induction of asthma and low birth weight,
and to years for induction ofasthma, CHD,
and lung cancer.
Table 1. Exposure period that can be assessed with different indicators of ETS.
Current
Frequency of or past
Indicator of ETS measurements Hours Days Months Years exposure
Air concentrations Once X C
of nicotine or RSPs Repeated X X C
Continuous X X C
monitoring
Urine, salivary Once X P
plasma cotinine Repeated X X P
Hair nicotine Once X P
Repeated X X P
4-ABP-Hb adduct Once X P
Repeated X X P
Questionnaire Once X X X X C, P
Repeated X X X C, P
Abbreviations: C, current; P, past; 4-ABP-Hb adduct, hemoglobin adduct of4-aminobiphenyl.
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Table 2. Latency period for different health outcomes.
Health outcome Hours Days Months Years
Asthma
Exacerbation X X
Induction X X
Low birth weight X
Coronary heart
disease
Angina X
Induction X
Lung cancer X
Table 3, which combines information
from Tables 1 and 2, synthesizes the exposure
assessment methods suitable for different
health outcomes. Single and continuous
measurements ofair concentrations of ETS
markers are appropriate for conditions with a
short latency period such as exacerbation of
asthma and angina. Repeated measurements
can be used to assess exposure related to
induction of asthma and low birth weight.
Single measurements ofcotinine in body flu-
ids can be used in estimating risk for exacer-
bation of asthma and angina, whereas
repeated measurements are suitable for induc-
tion of asthma and low birth weight. Hair
nicotine content and the hemoglobin adduct
of4-ABP provide an assessment ofexposure
during months and are suitable for induction
of asthma and low birth weight. Repeated
measurements ofthese biomarkers can pro-
vide an assessment ofexposure for years and
can thus be used for induction ofasthma, low
birth weight, CHD, and lung cancer. Finally,
since questionnaires can be focused to pro-
vide exposure assessment for any time period,
they are useful for all the health outcomes.
They are particularly suited to studying dis-
eases with very long latency periods such as
CHD and lung cancer. In addition to consid-
eration ofthe latency period and the need for
assessment ofcurrent or past exposure, the
relevant time-exposure profile for the health
outcome ofinterest also should be considered
when choosing the appropriate exposure
assessment method. For example, high peak
values could be registered by continuous
monitoring ofmarker concentrations in the
air, whereas average levels over longer time
periods could be measured with repeated air
concentration determinations combined with
questionnaire-derived time-activity data.
Cumulative exposure over long time periods
could be assessed with hair nicotine content,
4-ABP hemoglobin adduct levels, or indices
based on questionnaire information.
Some markers might be particularly
relevant for specific health effects depending
on the phase of ETS represented by the
marker, the site ofdeposition, and the target
tissue ultimately reached by the marker.
Table3. Appropriate exposure assessment methods for different health outcomes.
Air conc. Urine, salivary Hair 4-ABP-Hb
Health outcome (nicotine or RSP) plasma cotinine nicotine adduct Questionnaire
Asthma
Exacerbation O,C 0 0
Induction R R O,R O,R O,R
Low birth weight R R O, R O, R O, R
Coronary heart disease
Angina O,C 0 0
Induction R R O,R
Lung cancer R R O, R
Abbreviations: C, continuous monitoring, conc., concentrations, 0, one measurement; R, repeated measurements.
Table 4. Summary of indoor air nicotine and RSP concentrations associated with smoking occupancy in residential
and work environments in field studies with at least 15 observations.a
Range in Minimum-maximum Range in Minimum-maximum
mean air nicotine of air nicotine mean air RSPb of air RSPb
Microenvironment conc. (pg/m3) conc. (pg/m3) conc. (pg/m3) conc. (pg/m3)
Residences 2.2-19 0.1-292 12-430 0.7-1100
Offices 1.1-10.0 0-71.5 28-133 0-1088
Otherworkplaces 4.3-14 < 1.6-167 36-300 6-3580
Restaurants and/or bars 4.3-22 0-450 53-126 0-685
aBased on review by Guerin et al.(12).hRSP levels related to smoking occupancy were calculated by subtracting the average level in
nonsmoking environments (i.e., the background level) from that observed in the smoking environments for each study (when applica-
ble) before taking it into account in this summarytable.
Information on specific compounds biologi-
cally relevant for different health outcomes is
sparse, with the exception of carcinogenic
effects (1,4,23). Hypotheses can be formed;
but in the case ofETS, interactions among
different compounds may be essential for the
health effects. Carcinogen adducts, even if
measured in blood, may be the most appro-
priate indicator for cancer risk. For asthma,
both gas-phase and particulate-phase markers
may be relevant; exacerbations might be trig-
gered by deposition ofparticles and gaseous
compounds in the upper airway and bronchi.
In addition to other mechanisms, carbon
monoxide has been suggested as a factor in
exacerbation ofangina (24). Further research
on the pathogenesis ofETS-related diseases is
needed before recommendations can be made
on the basis of biologic relevance of any
individual compound.
ETS Levels in the Work and
Residential Environments
Comparison oftheIndoorAir
Concentrations ofETSMarkers
Since most epidemiologic data on health
effects ofETS come from studies assessing
ETS exposure at home, we review and com-
pare data available on ETS levels in both
work and residential environments. Two
reviews on the topic were published in 1992
(1,12). In addition, U.S. studies on ETS
exposure in the workplace and home were
summarized recentlyby Hammond (25).
Guerin and co-workers (12) reviewed
major studies, defined as those with at least 15
observations, that had measured air nicotine
and/or RSP concentrations in different envi-
ronments. A summary ofthese findings is pre-
sented in Table 4. The average air nicotine
levels were comparable between residential
environments and work situations other than
officeworkbutslightlylower in officeenviron-
ments. The highest nicotine levels have been
observed in bars and restaurants or in small
enclosed spaces with minimal ventilation, e.g.,
small offices, cars, and aircraft. Indoor RSP
concentrations associated with smoking occu-
pancy were also comparable between residen-
tial environments and work environments
other than offices, but the upper range of
mean concentrations was slightly lower in
offices. The RSP values in Table 4 were
achieved by subtracting the average level in
nonsmoking environments from that observed
in the smoking environments for each study.
RSP levels in nonsmoking households were
about half or less those related to smoking
occupancy. Figures 3 and 4 show the range of
average nicotine and RSP concentrations as
well as the range ofmaximum and minimum
values from smoking occupancy by different
indoor environments, according to the review
by U.S. Environmental Protection Agency
(1). Only studies with sampling times of4 hr
or greaterwere included in the residential and
office environments. The mean nicotine con-
centrations were comparable between home
and office environments, whereas the maxi-
mum concentrations were higher in office
environments. The mean and maximum
RSP concentrations were somewhat higher in
residential than in office environments.
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Figure 3. Range of average nicotine concentrations from selected studies and maxi-
mum and minimum values related to smoking occupancy in different indoor environ-
ments. Abbreviations: max., maximum; min., minimum. For residential and office
environments, only studies with sampling time of 4 hr or greater were included.
Reprinted from the report bythe U.S. Environmental Protection Agency (1).
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Figure 4. Range of average RISP concentrations from selected studies and maximum
and minimum values related to smoking occupancy in different indoor environments.
RSP values represent the contribution over background levels without smoking. For resi-
dential and office environments, only studies with sampling time of 4 hr or greater were
included. Reprinted from the report by the U.S. Environmental Protection Agency (1).
The highest values ofboth nicotine and RSP
concentrations were observed in restaurants
and transportation.
More recent studies have usually shown
somewhat lower concentrations ofnicotine in
both residential and work environments. In
Stockholm, Sweden, personal monitoring of
nicotine and RSP exposures was conducted in
1994 among 190 nonsmokers who were
either housewives or househusbands or
worked in 1 of 12 selected nonindustrial occu-
pations (26). Among ETS-exposed house-
wives and househusbands, the mean 24-hr
concentration of nicotine was 3.1 ,ug/m3
(range, 0.2-7.5 ,ug/m3); the mean 24-hr con-
centration of RSP was 51 pg/m3 (range,
15-154 pg/m3). Among the working subjects,
the mean concentrations for ETS exposure in
the home (sampling outside ofwork hours;
mean, 15 hr) were 0.3 pg/m3 (range, 0.1-1.6
pg/m3) for nicotine and 27 pg/m3 (range,
7.4-63 pg/m3) for RSP. The mean concentra-
tions for work exposure (sampling during
work hours; mean, 7 hr) were 0.5 pg/m3
(range, 0.1-3.1 pg/m3) for nicotine and
24 pg/m3 (range, 9.7-70 pg/m3) for RSP. In a
large study of 16 metropolitan areas of the
United States in 1993-1994, personal sam-
pling was performed in 1,498 subjects repre-
senting a variety ofoccupations in both office
and nonoffice environments (27). The smok-
ing status of the environment was first classi-
fied by response to a screening questionnaire,
then confirmed by a diary report. Subjects
with salivary cotinine levels of 15 ng/mL or
more were excluded as potential active smok-
ers. The mean 8-hr nicotine and RSP concen-
trations related to ETS exposure in the
workplace were 2.4 pg/m3 (95th percentile,
10.8 pg/m3) and 49.4 pg/m3 (95th percentile,
145 pg/m3), respectively. The corresponding
mean 16-hr concentrations related to home
exposure (nonwork exposure including possi-
ble exposures while shopping, commuting,
dining out, etc.) were 2.7 pg/m3 (95th per-
centile 7.9 pg/m3) and 44.1 pg/m3 (95th
percentile, 125 pg/m3), respectively.
Table 5 presents a summary of the
geometric mean and median air nicotine
concentrations as well as the range of
concentrations in different occupational
settings and in homes in the United States,
according to the recent review by Hammond
(25). The values for occupational concentra-
tions are from measurements in work areas of
nonsmokers. The mean nicotine concentra-
tions in offices allowing smoking were gener-
ally between 2 and 6 pg/m3, and in diverse
blue-collar occupations mean concentrations
were between 1 and 6 pg/m3, although some
workplaces had higher means. In homes of
smokers, the mean nicotine concentrations
were generally between 1 and 3 pg/m3, indi-
cating slightly lower ETS exposure levels in
residential than in work environments. The
mean and median concentrations were some-
what higher in office environments than in
other work environments, probably attribut-
able to the larger size and better ventilation of
the nonoffice work areas. In a large study of
25 Massachusetts work sites, including office
environments and different production work
areas, work site smoking policy had a strong
effect on indoor air nicotine concentrations
(28). The median values in offices were
Table 5. Summary of geometric mean and median air nicotine concentrations and minimum and maximum concentra-
tions in different types ofworkplaces allowing smoking as well as in homes in the United States.ab
Range in geometric Range in median Minimum-maximum
mean air nicotine air nicotine of air nicotine
Microenvironment concentration (pg/m3) concentration (pg/m3) concentrations(pg/m3)
Offices 0.80-48.32 LD or 0.60-48.35 LD or < 0.05-71.50
Nonoffice workplaces, including 0.18-16.80 0.10-10.00 < 0.05-126.00
manufacturing (chemicals, dyes,
paper products, etc.), fire stations,
railroads, barber shops, hospitals,
and aircraft
Homes 1.50-5.80 1.00-3.30 0.10-28.60
LD, limit of detection. "Based on review by Hammond (25). "the concentrations in occupational settings are measured in work areas
of nonsmokers.
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8.6pIg/m3 at work sites that allowed smoking,
1.3 pJg/m3 in sites that restricted smoking,
and 0.3 pg/m3 in sites that banned smoking.
The corresponding median concentrations in
nonoffice workspaces were 2.3, 0.7, and
0.2 pg/m3, respectively.
Conclusions concerning the comparison
ofthe indoor air nicotine and RSP levels in
residences with offices and other workplaces
are somewhat different in the three reviews,
which probably reflects the differences in
selection criteria applied to include individual
studies in each review. However, the average
concentrations ofthese markers seem quite
similar in both home and work environ-
ments, with some special work environments
such as restaurants and bars representing
exceptionally high levels. Unfortunately, none
ofthe reviewed studies evaluated ETS marker
concentrations in a random sample of the
U.S. population.
The LinkbetweenSmokingRate and
IndoorAirMarkerConcentrations
Estimates of the relation between smoking
rate in residences or workplaces and indoor
air concentrations ofnicotine or RSP provide
an important link for risk assessment because
most ofthe human studies on health effects
ofETS have assessed ETS exposure based on
questionnaire reports. Several experimental
studies as well as field studies with realistic
smoking conditions have applied mass bal-
ance models to predict ETS concentrations
from cigarette smoking rate in indoor spaces
(29). Indoor concentrations ofRSP, CO, or
nicotine have been measured to validate these
models, and good agreement was seen
between observed and predicted indoor con-
centrations (29-32). In a recent article
including theoretical considerations and a
review of previous studies, Ott concluded
that cigarette smoking is well suited for mak-
ing accurate predictions ofmarker concentra-
tions applying the mass balance law (29),
which is stated as follows: "The average con-
centration in a well-mixed indoor setting is
computed as the source strength divided by
the product ofthe volume ofthe setting and
the air change rate ofthe setting."
Table 6 presents estimates ofthe relation
between questionnaire-reported smoking
rate in residences or workplaces and indoor
concentrations ofnicotine and/or RSP from
selected studies. In 1986 Leaderer and
Hammond (33) studied 96 residences in the
Onondaga and Suffolk counties of New
York State. They found linear relations
between diary-reported total number ofcig-
arettes smoked during 1 week in the resi-
dences and 1-week residential nicotine and
RSP levels. Monitoring ofnicotine and RSP
was conducted in the main living area (liv-
ing room or family room). These relations
are demonstrated in Figure 5. In addition,
the nicotine and RSP concentrations were
highly correlated and the RSP/nicotine ratio
was 10.8.
Concluding Remarks
Two types of estimates are needed for a
quantitative risk assessment of the health
effects resulting from occupational ETS expo-
sure: an unbiased estimate of the exposure-
effect (or dose-response) relation between
ETS and the health effect ofinterest, and esti-
mates ofthe distribution ofETS levels in dif-
ferent workplaces. The estimate of the
exposure-effect relation can be derived either
from individual studies or from a meta-analy-
sis or pooled analysis ofindividual data. By
combining the exposure-effect relation with
information on exposure distribution for a
population of interest, we can calculate the
proportions of the exposed disease cases
(attributable proportion or etiologic fraction)
and of all disease cases in this population
(population-attributable proportion) attribut-
able to occupational ETS exposure. We can
also estimate the excess number of cases
resulting from specified exposure conditions.
Several dimensions ofthe exposure profile
should be taken into account when assessing
ETS exposure for estimating an exposure-
effect relation. These include the magnitude
ofexposure and the biologically relevant time
specificity ofexposure (9). The magnitude of
exposure is determined by the ETS source
strength, the environmental factors that mod-
ify concentrations, and the duration ofexpo-
sure. The magnitude ofbiologically effective
dose is determined also by factors affecting
uptake of ETS and metabolism of com-
pounds absorbed. Time specificity-related
issues include consideration of the latency
period for each health outcome of interest,
the time-exposure profile relevant for differ-
ent disease mechanisms, and the sensitive age
period with regard to different health effects.
The most appropriate indicator ofETS for
exposure assessment for each health outcome
Table 6. Estimates of the relation between question-
naire-reported smoking rate in residences or workplaces
and indoor air concentrations of RSP and nicotine from
selected studies.
Quantity of RSP conc.a Nicotine conc.a
smoking, reference (pg/m3) (pg/m3)
Per 1 smoker in home, 20
Spengler et al. (34)
Per . 1 smokers in home, 17.3 2.1
Coultas et al. (35)
Per packb(total amount 6.4 0.6
smoked in a week),
Leaderer and Hammond (33)
aSampling periods were 24 hr in Spengler etat. (34), 24 hr in
Coultas et al. 1351, 1 week in leaderer and Hammond (33). bOne
pack = 20 cigarettes.
depends on the time specificity dimensions
mentioned and on the time period that can
be assessedwith different methods.
Consideration of these different aspects
ofexposure profile is critical, since exposure
assessment that does not take into account
these aspects will reduce the sensitivity ofthe
study to detect a true effect or at least it will
underestimate the effect. An attempt to
quantify the magnitude ofexposure increases
the power of the study to detect adverse
effects. Time specificity of exposure in rela-
tion to outcome has often received less atten-
tion, especially in cross-sectional and
case-control studies, and can be a source ofa
failure to detect health effects. For example,
assessing only current ETS exposure in
studies oflung cancer risk may lead to a false
negative result if current exposure is not
related to earlier exposure that is more rele-
vant, given the long latency period oflung
cancer. Assessing average ETS levels during a
specified time period may not be related to
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Figure 5. (A) Vapor-phase nicotine and (B) RSP
concentrations measured during 1 week in 96 resi-
dences as a function of the number of reported ciga-
rettes smoked (T) in these residences during the
sampling period. n, the number of residences that were
studied. r2, the proportion of variation in nicotine/RSP
concentrations explained by the regression model.
Numbers 1-9 refer to the number of observations at the
same concentrations. Closed circles indicate that cigar
or pipe smoking was reported. Reprinted from Leaderer
and Hammond (33) with permission of the American
Chemical Society.
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exacerbations ofasthma, whereas high peak
exposures may be followed by increased
episodes of asthma exacerbation. A third
example is studies ofeffects offetal exposure;
the developmental period during which
exposure takes place is essential with regard
to detecting health effects.
In three extensive reviews of indoor air
nicotine and/or RSP concentrations in differ-
ent microenvironments, the levels were
essentially comparable between work and res-
idential environments in the United States
and other countries (1,12,25). According to
the most recent review ofnicotine concentra-
tions, the levels are slightly higher in the
workplace compared to residential environ-
ments where smoking takes place (25). The
nicotine levels are somewhat higher in offices
compared to blue-collar occupational set-
tings, probably attributable to larger size and
better ventilation ofnonoffice work areas. In
some special work environments such as bars
and restaurants, the levels may be extremely
high. Data from experimental and field
studies show good agreement between ETS
marker indoor concentrations predicted from
cigarette smokingwith models applying mass
balance law and measured concentrations of
RSP, CO, and nicotine. Some data are avail-
able on the relations between questionnaire-
reported rate ofsmoking and indoor ETS
marker concentrations. However, more
research is needed to achieve more accurate
and precise estimates ofthe relations between
questionnaire-reported amount ofsmoking
and indoor air marker concentrations, since
most ofthe health effect studies have based
ETS exposure assessment on questionnaires.
When better estimates are obtained, infor-
mation on the distribution ofETS exposure
levels in different occupational settings can
be better used for assessing health risks due
to workplace ETS exposure.
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